Akademska digitalna zbirka SLovenije - logo
VSE knjižnice (vzajemna bibliografsko-kataložna baza podatkov COBIB.SI)
  • Zdravljenje hiperlipidemije z lovastatinom pri bolnikih s presajeno ledvico in ciklosporinsko imunosupresijo : magistrsko delo
    Kovač, Damjan, 1963-
    Atherosclerotic cardiovascular diseases are one of the major causes of death in patients with transplanted kidneys. Hyperlipidemia, especially elevated concentrations of total and LDL cholesterol, ... which is frequent in these patients, is important in the etiopathogenesis of atherosclerosis. Different drugs have been tried to counteract hyperlipidemia in patients with transplanted kidneys receiving Cy, but the results were very ambiguous and connected to side effects. Lovastatin is a very effective lipid-lowering drug,but it can cause damage to the skeletal muscles and liver in patients whoconcomitantly receive Cy. We wanted to evaluate the possibility of reachingthe expected decrease of serum concentrations of total cholesterol, LDL cholesterol and triglycerides with lovastatin in daily doses of 20 mg, without causing signs of damage to the liver and to skeletal muscles which canbe detected as well by quantitative electromyography in patients with transplanted kidney on cyclosporine immunosuppression who participated in thisprospective clinical study. We wanted to evaluate the possibility of additional lowering the concentrations of total cholesterol, LDL cholesterol and triglycerides by increasing daily doses of lovastatin from 20 mg to 30 mg.We also wanted to evaluate the influence of lovastatin therapy on the serumconcentrations of HDL cholesterol, Lp(a), Apo A-I and Apo B. Twelve patients with stable kidney function, who had a concentration of LDL cholesterol greater than 4.1 mmolž1 after a 3-month lipid-lowering diet participated in the study. All the patients were receiving Cy and corticosteroids and didnćt have signs of damage to the skeletal muscles and liver at the beginning of study. In the first 3 months they received lovastatin in daily doses of 20 mg. After 3 months we increased the daily doses of lovastatin to 30 mg in 5 patients who still had a concentration of LDL cholesterol greater than 3.5 mmol/1. (Abstract truncated at 2000 characters.)
    Vrsta gradiva - magistrsko delo ; neleposlovje za odrasle
    Založništvo in izdelava - Ljubljana : [D. Kovač], 1994
    Jezik - slovenski
    COBISS.SI-ID - 1212692

Knjižnica/institucija Kraj Akronim Za izposojo Druga zaloga
MF, Centralna medicinska knjižnica, Ljubljana Ljubljana CMK na dom 1 izv.
Narodna in univerzitetna knjižnica, Ljubljana Ljubljana NUK v čitalnico 1 izv.
loading ...
loading ...
loading ...

Vnos na polico